Temptime VP global customer development Christopher Caulfield spoke with Drug Store News about how the company’s tools helps pharmacies deliver value to patients and the healthcare system.
Specialty Pharmacy News
Kåre Schultz Schultz has had a nearly 30-year career in the pharmaceutical and healthcare industries, including a long stint at Novo Nordisk, where he eventually became COO.
With the acquisition, the company said it would expand the scope of Value Specialty Pharmacy’s business while retaining the current leadership and employees of Restore Rx — and its prime location near FedEx's Memphis hub.
According to CDC data, when taken consistently, PrEP has been shown to reduce the risk of HIV infection in people who are at high risk by more than 90%.
J.D. Power’s 2017 U.S. Pharmacy Study is showing a drop in overall customer satisfaction for an industry that typically ranks among the highest-scoring ones assessed by the market research company.
Among the potential treatments Gilead will acquire is Kite’s most advanced therapy candidate, axicabtagene ciloleucel (axi-cel), a cancer-fighting therapy expected to be the first to market to treat refractory aggressive non-Hodgkin lymphoma, with a Food and Drug Administration decision date of Nov. 29.
The FDA approved Novartis' Kymriah (tisagenlecleucel) for certain pediatric and young adult patients with a form of acute lymphoblastic leukemia.